Cholestatic jaundice due to co-trimoxazole.
A patient developed cholestatic jaundice following therapy with co-trimoxazole. Inadvertent re-challenge with the drug resulted in further clinical and biochemical deterioration, but complete recovery ensued on stopping this drug.
D000368:Aged; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D013420:Sulfamethoxazole / Q000009:adverse effects*; D014295:Trimethoprim / Q000009:adverse effects*
D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole